CONSEQUENCES OF ABRUPT DISCONTINUATION OF ANTI TUBERCULAR THERAPY (ATT) DUE TO ADVERSE DRUG REACTION (ADRS): A TERTIARY HOSPITAL BASED STUDY. PharmaNexus Bulletin, [S. l.], v. 2, n. 2, p. 1–5, 2026. Disponível em: https://lapinjournals.com/index.php/pnb/article/view/208. Acesso em: 27 aug. 2026.